| Dataset | GSEAGood_collapsed_to_symbols.cls2class |
| Phenotype | cls2class.cls |
| Upregulated in class | Metastatic |
| GeneSet | REGULATION_OF_MEMBRANE_POTENTIAL |
| Enrichment Score (ES) | 0.59979 |
| Normalized Enrichment Score (NES) | 1.5769044 |
| Nominal p-value | 0.0 |
| FDR q-value | 0.5529591 |
| FWER p-Value | 0.99 |

| PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|
| 1 | SOD1 | SOD1 Entrez,  Source | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 136 | 1.077 | 0.2527 | Yes |
| 2 | BNIP3 | BNIP3 Entrez,  Source | BCL2/adenovirus E1B 19kDa interacting protein 3 | 473 | 0.780 | 0.4096 | Yes |
| 3 | BAX | BAX Entrez,  Source | BCL2-associated X protein | 487 | 0.771 | 0.5998 | Yes |
| 4 | NDUFS1 | NDUFS1 Entrez,  Source | NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) | 3135 | 0.234 | 0.3667 | No |
| 5 | GLRA1 | GLRA1 Entrez,  Source | glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man syndrome) | 3612 | 0.181 | 0.3592 | No |
| 6 | BCL2 | BCL2 Entrez,  Source | B-cell CLL/lymphoma 2 | 4760 | 0.062 | 0.2484 | No |
| 7 | IFI6 | IFI6 Entrez,  Source | interferon, alpha-inducible protein 6 | 5737 | -0.046 | 0.1523 | No |
| 8 | GRK1 | GRK1 Entrez,  Source | G protein-coupled receptor kinase 1 | 5818 | -0.055 | 0.1571 | No |
| 9 | BAK1 | BAK1 Entrez,  Source | BCL2-antagonist/killer 1 | 6425 | -0.139 | 0.1250 | No |
| 10 | CHRNA1 | CHRNA1 Entrez,  Source | cholinergic receptor, nicotinic, alpha 1 (muscle) | 7291 | -0.309 | 0.1066 | No |
| 11 | BCL2L1 | BCL2L1 Entrez,  Source | BCL2-like 1 | 7512 | -0.370 | 0.1742 | No |

